This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Daegu Gyeongbuk Institute of Science and Technology, Enzynomics Co. Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Ki Hoon Nam: Innovator in DNA Glycosylase Technology
Introduction
Ki Hoon Nam is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of enzymes that enhance the efficiency of polymerase chain reactions (PCR). His innovative work has implications for various applications, including diagnostics and research.
Latest Patents
Ki Hoon Nam holds a patent for a "Mutant Uracil DNA glycosylase with improved thermal sensitivity." This invention features a mutant UDG that exhibits enhanced thermal sensitivity compared to its wild-type counterpart. The mutant UDG does not inhibit PCR reactions, making it particularly advantageous for the development of PCR/qPCR premixes and diagnostic kits that require lower temperatures during melting and amplification steps. He has 1 patent to his name.
Career Highlights
Throughout his career, Ki Hoon Nam has worked with notable organizations, including Enzynomics Co. Ltd. and the Daegu Gyeongbuk Institute of Science and Technology. His experience in these institutions has allowed him to refine his expertise in enzyme technology and its applications in molecular biology.
Collaborations
Ki Hoon Nam has collaborated with talented individuals in his field, including Jeongyeon Yoon and Minjae Seo. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in biotechnology.
Conclusion
Ki Hoon Nam is a distinguished inventor whose work in mutant UDG technology has the potential to revolutionize PCR applications. His contributions to the field highlight the importance of innovation in biotechnology and its impact on scientific research and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile